132 cases of esophageal cancer recurrence and metastasis after multivariate analysis.docVIP

 PAGE \* MERGEFORMAT 14 132 cases of esophageal cancer recurrence and metastasis after multivariate analysis [Abstract] Objective To investigate the impact of postoperative recurrence and prognostic factors. Method in our hospital from January 1998 to December 2004 132 patients admitted to metastasis and recurrence of esophageal cancer were retrospectively analyzed. All cases were according to clinical TNM stage (UICC 1987, staging 12 patients with stage , of the 45 cases, of 75 cases. Uygur 73 cases, 59 cases of Han nationality. SPSS12.0 software used for data processing. recurrence and survival factors by COX multivariate analysis, the survival rate calculated using the Kaplan-Meier method and with the Log-rank test, rates were compared by 2 test. Results lymph node metastasis, 75 cases, 56.8%, hematogenous metastasis in 14 cases, accounting for 10.6%, mixed transfer 26 cases, accounting for 19.7%, anastomotic recurrence in 17 cases, accounting for 12.88% .3,5 year recurrence rate was 76.4%, 89.28%. the median survival time was 18.5 months .3,5 free survival rates were 24.6% , 11.72%. relapse after 3,5 year survival rate was 15.26%, 0%. nationalities, surgical procedure, TNM stage, surgery with or without chemotherapy, radiotherapy is the impact of postoperative recurrence and metastasis factors. surgical method TNM stage, surgery with or without chemotherapy, radiation therapy is the recurrence of esophageal cancer patients with an important factor in survival. Conclusion to regulate surgery combined therapy (radiotherapy, chemotherapy and other measures, can improve survival in patients with esophageal cancer and quality of life. [Keywords:] Analysis of prognostic factors of esophageal cancer recurrence [Abstract] Objective To investigate the relevant factors of recurrence and metastasis and prognosis with esophageal cancer after operation.Methods In our hospital from January 1998 to December 2004,132 cases of esophageal cancer with recurrence an